These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18346407)

  • 21. Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer.
    Aprile G; Mazzer M; Moroso S; Puglisi F
    Anticancer Drugs; 2009 Apr; 20(4):217-29. PubMed ID: 19247178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An open-label, multicenter study of outpatient capecitabine monotherapy in 631 patients with pretreated advanced breast cancer.
    Venturini M; Paridaens R; Rossner D; Vaslamatzis MM; Nortier JW; Salzberg M; Rodrigues H; Bell R
    Oncology; 2007; 72(1-2):51-7. PubMed ID: 18004077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical picture: leopard-like vitiligo with capecitabine.
    Schmid-Wendtner MH; Wendtner CM; Volkenandt M; Heinemann V
    Lancet; 2001 Nov; 358(9293):1575. PubMed ID: 11716883
    [No Abstract]   [Full Text] [Related]  

  • 24. Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer.
    Blum JL; Barrios CH; Feldman N; Verma S; McKenna EF; Lee LF; Scotto N; Gralow J
    Breast Cancer Res Treat; 2012 Dec; 136(3):777-88. PubMed ID: 23104222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe hypertriglyceridaemia associated with the use of capecitabine.
    Polinder-Bos HA; Kok EE; van de Wiel A; Spiering W; Wielders JP; Bloemendal HJ
    Neth J Med; 2012 Mar; 70(2):104. PubMed ID: 22418760
    [No Abstract]   [Full Text] [Related]  

  • 26. Lethal toxicity of capecitabine due to abusive folic acid prescription?
    Clippe C; Freyer G; Milano G; Trillet-Lenoir V
    Clin Oncol (R Coll Radiol); 2003 Aug; 15(5):299-300. PubMed ID: 12924465
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of capecitabine in first-line treatment for patients with metastatic breast cancer.
    Gelmon K; Chan A; Harbeck N
    Oncologist; 2006; 11 Suppl 1():42-51. PubMed ID: 16971739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of capecitabine-induced coronary microspasm in a patient with rectal cancer.
    Arbea L; Coma-Canella I; Martinez-Monge R; García-Foncillas J
    World J Gastroenterol; 2007 Apr; 13(14):2135-7. PubMed ID: 17465463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between capecitabine and brivudin in a patient with breast cancer.
    Baena-Cañada JM; Martínez MJ; García-Olmedo O; Jiménez-Bárcenas R; Muriel-Cueto P
    Nat Rev Clin Oncol; 2010 Jan; 7(1):55-8. PubMed ID: 20029444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy.
    Fernandes NF; Rosenbach M; Elenitsas R; Kist JM
    Arch Dermatol; 2009 Mar; 145(3):340-1. PubMed ID: 19289781
    [No Abstract]   [Full Text] [Related]  

  • 31. Hypertriglyceridaemia-induced pancreatitis: a contributory role of capecitabine?
    Chan HY; Ng CM; Tiu SC; Chan AO; Shek CC
    Hong Kong Med J; 2012 Dec; 18(6):526-9. PubMed ID: 23223655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapy-related acute promyelocytic leukemia after chemoradiotherapy with capecitabine for rectal adenocarcinoma.
    Rashidi A; Man L; Howard JR; Atienza D; Fisher SI
    Leuk Lymphoma; 2014 Mar; 55(3):683-4. PubMed ID: 23837492
    [No Abstract]   [Full Text] [Related]  

  • 33. A retrospective study evaluating a fixed low dose capecitabine monotherapy in women with HER-2 negative metastatic breast cancer.
    Ambros T; Zeichner SB; Zaravinos J; Montero AJ; Ahn E; Aruna M; Kronish L; Mahtani RL; Vogel CL
    Breast Cancer Res Treat; 2014 Jul; 146(1):7-14. PubMed ID: 24899084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Capecitabine-induced acute myeloid leukaemia.
    Tansley S; Gibbons S
    N Z Med J; 2009 May; 122(1294):118-9. PubMed ID: 19465957
    [No Abstract]   [Full Text] [Related]  

  • 35. Capecitabine in gastric cancer.
    Okines A; Chau I; Cunningham D
    Drugs Today (Barc); 2008 Aug; 44(8):629-40. PubMed ID: 18846273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer.
    Gajria D; Gonzalez J; Feigin K; Patil S; Chen C; Theodoulou M; Drullinsky P; D'Andrea G; Lake D; Norton L; Hudis CA; Traina TA
    Breast Cancer Res Treat; 2012 Jan; 131(1):111-6. PubMed ID: 21898114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Myocardial ischaemia as a result of treatment with capecitabine].
    van Halteren HK; Liem AH; Planting AS
    Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1469-73. PubMed ID: 17633978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Capecitabine and PPE syndrome: a case report.
    LoRusso PM
    Breast J; 2003; 9(1):64-5. PubMed ID: 12558679
    [No Abstract]   [Full Text] [Related]  

  • 39. Safety and efficacy of oral vinorelbine and capecitabine combination for metastatic breast cancer.
    Di Seri M; De Sanctis R; Quadrini S; Adua D; Stumbo L; Del Signore E; Gori B; Grassi P; Basile ML; Longo F
    J Chemother; 2011 Apr; 23(2):110-3. PubMed ID: 21571629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment.
    Prado CM; Baracos VE; McCargar LJ; Reiman T; Mourtzakis M; Tonkin K; Mackey JR; Koski S; Pituskin E; Sawyer MB
    Clin Cancer Res; 2009 Apr; 15(8):2920-6. PubMed ID: 19351764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.